Quick Answer
BioCorRx Inc. reported Stockholders Equity of -$11.22 million for the year ending 2025.
- BioCorRx Inc. showed an increase of +7.4% in Stockholders Equity from 2024 to 2025.
- This data is from BioCorRx Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2008: $41.00 | Q2 2011: $4.03 million | Q3 2011: $4.02 million | Q1 2012: $3.48 million | Q3 2012: $2.96 million | Q1 2013: $2.97 million | Q2 2013: $2.88 million | Q3 2013: $2.87 million | Q1 2014: -$583.3 thousand | Q2 2014: $241.1 thousand | Q3 2014: $523.5 thousand | Q1 2015: $151.1 thousand | Q2 2015: -$3.24 million | Q3 2015: -$3.53 million | Q1 2016: -$3.61 million | Q2 2016: -$4.52 million | Q3 2016: -$6.95 million | Q1 2017: -$44.05 million | Q2 2017: -$1.69 million | Q3 2017: -$2.63 million | Q4 2017: -$3.89 million | Q1 2018: -$4.37 million | Q2 2018: -$4.01 million | Q3 2018: -$4.83 million | Q1 2019: -$6.38 million | Q2 2019: -$3.15 million | Q3 2019: $14.4 thousand | Q4 2019: -$1.06 million | Q1 2020: -$2.02 million | Q2 2020: -$2.69 million | Q3 2020: -$3.40 million | Q1 2021: -$3.49 million | Q2 2021: -$4.49 million | Q3 2021: -$5.80 million | Q1 2022: -$6.75 million | Q2 2022: -$7.34 million | Q3 2022: -$7.08 million | Q1 2023: -$8.70 million | Q2 2023: -$8.58 million | Q3 2023: -$9.13 million | Q1 2024: -$10.74 million | Q2 2024: -$11.00 million | Q3 2024: -$11.83 million | Q1 2025: -$11.56 million | Q2 2025: -$12.62 million | Q3 2025: -$13.48 million.
- Over the full 17 years of available data (2009 to 2025), BioCorRx Inc.'s Stockholders Equity has declined by 61,826.5%.
- Historical annual values: Fiscal year 2025: -$11.22 million | Fiscal year 2024: -$12.12 million | Fiscal year 2023: -$9.82 million | Fiscal year 2022: -$8.08 million | Fiscal year 2021: -$6.96 million | Fiscal year 2020: -$4.21 million | Fiscal year 2019: -$1.06 million | Fiscal year 2018: -$5.71 million | Fiscal year 2017: -$3.89 million | Fiscal year 2016: -$8.13 million | Fiscal year 2015: -$3.28 million | Fiscal year 2014: $306.3 thousand | Fiscal year 2013: $222.8 thousand | Fiscal year 2012: $2.84 million | Fiscal year 2011: $3.49 million | Fiscal year 2010: -$172.7 thousand | Fiscal year 2009: -$18.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: